VISION
Inspiring transformational change in the
field of oncology diagnostics
MISSION
To develop and deliver accurate, rapid, minimally
invasive oncology diagnostic products utilising our
patented MCM5 antibodies
Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Latest News
Arquer Diagnostics @Arquer Diagnostics
Our commitment to providing excellence in #cancer #diagnostics has been rewarded: #Arquer have been #certified by #BSI. We are dedicated to continuing to deliver quality products to our clinicians, patients, and partners. https://t.co/I1T7Sg3bV8
Arquer Diagnostics @Arquer Diagnostics
Sharing our #research on #cancer #diagnostics is vital for saving lives through accurate detection with our #ADXBLADDER technology. Find out more about #Arquer: https://t.co/FhOvCtBxtO https://t.co/hcxcezAOne
Arquer Diagnostics @Arquer Diagnostics
#Arquer's CEO Nadia will be speaking at Practicus' "Women in #LifeSciences: Pathways to Success" event on 17th April in #London. To attend, email charlotte.hood@practicus.com
#ArquerDx #ArquerDiagnostics #medical #science #health #oncology #diagnostics #womeninscience #Practicus https://t.co/Zzsx2SLhW4
Arquer Diagnostics @Arquer Diagnostics
#Smoking is often associated with lung #cancer, but in actuality, it plays a huge role in the development of #bladdercancer. Prolong your survival, and #quitsmoking today: https://t.co/p0c9JChBR5
#Arquer #ArquerDiagnostics #medical #health #oncology #diagnostics #stopsmoking https://t.co/bCpXw4KMvi
Arquer Diagnostics @Arquer Diagnostics
We received great feedback on our #ADXBLADDER technology, as we launched it at the 31st Urology Society of Saudi Arabia meeting in #Riyadh last month. Find out about our #research: https://t.co/3dHE0bSalg
#Arquer #ArquerDiagnostics #cancer #urologyconference #AlHobailMedical https://t.co/R0iCLsEV76
